W. Symonds

A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)

M. Palacios, Jill Denning, S. Wring, 2022, Pulmonary circulation.

Multiple-Dose Pharmacokinetics and Pharmacodynamics of Abacavir Alone and in Combination with Zidovudine in Human Immunodeficiency Virus-Infected Adults

D. Stein, Y. Lou, J. McDowell, 2000, Antimicrobial Agents and Chemotherapy.

Safety and Pharmacokinetics of Abacavir (1592U89) following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

S. Hetherington, Y. Lou, S. Lafon, 1999, Antimicrobial Agents and Chemotherapy.

Safety and Single-Dose Pharmacokinetics of Abacavir (1592U89) in Human Immunodeficiency Virus Type 1-Infected Children

R. Yogev, J. Shenep, S. Hetherington, 1999, Antimicrobial Agents and Chemotherapy.

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.

P. Volberding, C. Petropoulos, R. Grant, 1999, The Journal of infectious diseases.

Undetectable Cerebrospinal Fluid HIV RNA and β-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Active Antiretroviral Therapy-Treated Patients

J. Catalan, K. Marder, D. Clifford, 2005, Journal of acquired immune deficiency syndromes.

Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

J. Catalan, K. Marder, D. Clifford, 2007, PLoS clinical trials.